For years, people from CEOs to novelists have taken tiny amounts of psychedelics to support well-being. New research shows ...
Data to Support MindMed's Project Lucy in Preparing Phase 2b Trial for Anxiety Disorders NEW YORK, Nov. 2, 2020 /PRNewswire/ -- MindMed (NEO: MMED, OTCQB: MMEDF), the leading psychedelic medicine ...
LSD usage is on the rise among U.S. adults – especially young adults with depression. And the trend mirrors growing research into the psychedelic drug's ability to treat mental health disorders like ...
Scientists have identified a drug that appears to produce the antidepressant effects of LSD without the psychedelic side effects — at least in mice. Drugs like magic mushrooms and LSD can act as ...
University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...
A new study published in the journal Neuropsychopharmacology provided results from one of the first modern clinical investigations of its kind to compare the effects of psychedelic drugs lysergic acid ...
Patients in the MM-120 clinical trial open the door to a nondescript Lauderhill medical facility off Oakland Park Boulevard and find themselves staring at a large seed-of-life symbol on the wall, ...
Drugs like magic mushrooms and LSD can act as powerful and long-lasting antidepressants. But they also tend to produce mind-bending side-effects that limit their use. Now, scientists report in the ...
An incredible, first-of-its-kind trial testing the pain-killing properties of LSD microdoses has delivered the compelling suggestion that tiny, non-psychedelic doses of this infamous drug could serve ...